Chapter 8 Aqueous Humor Dynamics II. Clinical Studies

Current Topics in Membranes

Volumn 62, Issue , 2008, Pages 231-272

  Toris, Carol B ^a   Camras, Carl B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53049104701     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(08)00408-0     Document Type: Review

References (240)

1. Ambache N. Properties of irin, a physiological constituent of the rabbit iris. J. Physiol. 135 (1957) 114-132
2. Araie M., and Takase M. Effects of various drugs on aqueous humor dynamics in man. Jpn. J. Ophthalmol. 25 (1981) 91-111
3. Araie M., Yamamoto T., Shirato S., and Kitazawa Y. Effects of laser trabeculoplasty on the human aqueous humor dynamics: A fluorophotometric study. Ann. Ophthalmol. 16 (1984) 540-544
4. Armaly M.F. The consistency of the 1955 calibration for various tonometer weights. Am. J. Ophthalmol. 48 (1959) 602-611
5. Azevedo H., Ciarniello M.G., Rosignoli M.T., Dionisio P., and Cunha-Vaz J. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma. Eur. J. Ophthalmol. 13 (2003) 370-376
6. Ballintine E.J., and Garner L.L. Improvement of the coefficient of outflow in glaucomatous eyes. Arch. Ophthalmol. 66 (1961) 314-317
7. Bar-Ilan A., Pessah N.I., and Maren T.H. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics. Invest. Ophthalmol. Vis. Sci. 25 (1984) 1198-1205
8. Bartels S.P., Roth H.O., Jumblatt M.M., and Neufeld A.H. Pharmacological effects of topical timolol in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 19 (1980) 1189-1197
9. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox. A preliminary report. Am. J. Ophthalmol. 37 (1954) 13-15
10. Becker B. The decline in aqueous secretion and outflow facility with age. Am. J. Ophthalmol. 46 (1958) 731-736
11. Becker B., and Morton W.R. Topical epinephrine in glaucoma suspects. Am. J. Ophthalmol. 62 (1966) 272-277
12. Becker B., Pettit T.H., and Gay A.J. Topical epinephrine therapy of open-angle glaucoma. Arch. Ophthalmol. 66 (1961) 219-225
13. Bill A. Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 5 (1966) 45-54
14. Bill A. Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus). Exp. Eye Res. 6 (1967) 120-125
15. Bill A. Further studies on the influence of the intraocular pressure on aqueous humor dynamics in cynomolgus monkeys. Invest. Ophthalmol. 6 (1967) 364-372
16. Bill A., and Phillips C.I. Uveoscleral drainage of aqueous humour in human eyes. Exp. Eye Res. 12 (1971) 275-281
17. Bill A., and Wålinder P.-E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest. Ophthalmol. 5 (1966) 170-175
18. Brechue W.F., and Maren T.H. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Exp. Eye Res. 57 (1993) 67-78
19. Breinin G.M., and Gortz H. Carbonic anhydrase inhibitor acetazolamide (Diamox): A new approach to the therapy of glaucoma. AMA Arch. Ophthalmol. 52 (1954) 333-348
20. Brown J.D., and Brubaker R.F. A study of the relation between intraocular pressure and aqueous humor flow in the pigment dispersion syndrome. Ophthalmology 96 (1989) 1468-1470
21. Brubaker R.F. Determination of episcleral venous pressure in the eye. A comparison of three methods. Arch. Ophthalmol. 77 (1967) 110-114
22. Brubaker R.F. The flow of aqueous humor in the human eye. Trans. Am. Ophthalmol. Soc. 80 (1982) 391-474
23. Brubaker R.F. Flow of aqueous humor in humans. Invest. Ophthalmol. Vis. Sci. 32 (1991) 3145-3166
24. Brubaker R.F. Clinical evaluation of the circulation of aqueous humor. In: Tasman W., and Jaeger E.A. (Eds). Duane's Clinical Ophthalmology Vol. 3 (1997), Lippincott-Raven Publishers, Philadelphia 1-11
25. Brubaker R.F. Clinical measurements of aqueous dynamics: Implications for addressing glaucoma. In: Civan M.M. (Ed). The Eye's Aqueous Humor. From Secretion to Glaucoma Vol. 45 (1998), Academic Press, San Diego 233-284
26. Brubaker R.F., and Liesegang T.J. Effect of trabecular photocoagulation on the aqueous humor dynamics of the human eye. Am. J. Ophthalmol. 96 (1983) 139-147
27. Brubaker R.F., Nagataki S., Townsend D.J., Burns R.R., Higgins R.G., and Wentworth W. The effect of age on aqueous humor formation in man. Ophthalmology. 88 (1981) 283-287
28. Brubaker R.F., Nagataki S., and Bourne W.M. Effect of chronically administered timolol on aqueous humor flow in patients with glaucoma. Ophthalmology. 89 (1982) 280-283
29. Brubaker R.F., Ingram C.J., Schoff E.O., and Nau C.B. Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects. Ophthalmology 107 (2000) 283-287
30. Brubaker R.F., Schoff E.O., Nau C.B., Carpenter S.P., Chen K., and VanDenburgh A.M. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131 (2001) 19-24
31. Bucci M.G., Missiroli A., Pecori G.J., and Virno M. The local administration of propranolo in the therapy of glaucoma. Boll. Ocul. 47 (1968) 51-60
32. Burke J., Kharlamb A., Shan T., Runde E., Padillo E., Manlapaz C., and Wheeler L. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference. In: Reis D.J., Bousquet P., and Parini A. (Eds). The Imidazoline Receptor: Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine Vol. 763 (1995), The New York Academy of Sciences, New York 78-95
33. Bursell S.-E., Clermont A.C., Kinsley B.T., Simonson D.C., Aiello L.M., and Wolpert H.A. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. A video fluorescein angiography study. Invest. Ophthalmol. Vis. Sci. 37 (1996) 886-897
34. 2-adrenoceptors: Pharmacological and molecular biological evidence converge. Trends Pharmacol. Sci. 9 (1988) 356-361
35. 2α. Curr. Eye Res. 1 (1981) 205-209
36. Camras C.B., and Podos S.M. The role of endogenous prostaglandin in clinically-used and investigational glaucoma therapy. In: Bito L.Z., and Stjernschantz J. (Eds). The Ocular Effects of Prostaglandins and Other Eicosanoids Vol. 312 (1989), Alan R. Liss, Inc, New York, USA 459-475
37. 2α on IOP in glaucomatous monkey eyes. Invest. Ophthalmol. Vis. Sci. 31 (1990) 150 Abstract
38. Camras C.B., Chacko D.M., Schlossman A., and Posner A. Posner-Schlossman syndrome. In: Prepose J.S., Holland G.N., and Wilhelmus K.R. (Eds). Ocular Infection & Immunity (1996), Mosby-Year Book, Inc., St. Louis 529-537
39. Camras C.B., Haecker N.R., Zhan G., and Toris C.B. Aqueous humor dynamics in patients with pigment dispersion syndrome. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2207
40. Carlson K.H., McLaren J.W., Topper J.E., and Brubaker R.F. Effect of body position on intraocular pressure and aqueous flow. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1346-1352
41. 1 receptors in the human uveo scleral tissue by light microscope autoradiography. Int. Ophthalmol. 23 (1999) 171-179
42. Christiansen G.A., Nau C.B., McLaren J.W., and Johnson D.H. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 111 (2004) 1658-1662
43. 3 receptor agonist. J. Pharmacol. Exp. Ther. 293 (2000) 710-716
44. 3 dopamine receptors and brain natriuretic peptide. J. Ocul. Pharmacol. Ther. 20 (2004) 15-23
45. Coakes R.L., and Brubaker R.F. The mechanism of timolol in lowering intraocular pressure. In the normal eye. Arch. Ophthalmol. 96 (1978) 2045-2048
46. Coulangeon L.M., Sole M., Menerath J.M., and Sole P. Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension. Ophtalmologie 4 (1990) 156-161
47. 2 α. Arch. Ophthalmol. 105 (1987) 1112-1116
48. 2 α on aqueous humor dynamics in cynomolgus monkeys. Curr. Eye Res. 6 (1987) 1035-1044
49. Dailey B.A., Brubaker R.F., and Bourne W.M. The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am. J. Ophthalmol. 93 (1982) 232-237
50. Darier A. De l'extrait de capsule surrénales en thérapeutique oculaire. La Clinique Ophthalmologique. 6 (1900) 141-143
51. Diestelhorst M., and Krieglstein G.K. Does aqueous humor secretion decrease with age?. Int. Ophthalmol. 16 (1992) 305-309
52. Diestelhorst M., and Krieglstein G.K. Physiologic aging in aqueous humor minute volume of the human eye. Ophthalmologe 91 (1994) 575-577
53. Dinslage S., Hueber A., Diestelhorst M., and Krieglstein G.K. The influence of latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study. Graefes Arch. Clin. Exp. Ophthalmol. 242 (2004) 654-660
54. Ethier C.R., Read A.T., and Chan D.W.-H. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1991-1998
55. Friedenwald J.S. Tonometer calibration. An attempt to remove discrepancies found in the 1954 calibration scale for Schiotz tonometers. Trans. Am. Acad. Ophthalmol. Otolaryngol. 61 (1957) 108-123
56. Friström B., and Nilsson S.E.G. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Arch. Ophthalmol. 111 (1993) 662-665
57. Funk R.H.W., Gehr J., and Rohen J.W. Short-term hemodynamic changes in episcleral arteriovenous anastomoses correlate with venous pressure and IOP changes in the albino rabbit. Curr. Eye Res. 15 (1996) 87-93
58. Gaasterland D., Kupfer C., Ross K., and Gabelnick H.L. Studies of aqueous humor dynamics in man. III. Measurements in young normal subjects using norepinephrine and isoproterenol. Invest. Ophthalmol. 12 (1973) 267-279
59. Gaasterland D., Kupfer C., and Ross K. Studies of aqueous humor dynamics in man. IV. Effects of pilocarpine upon measurements in young normal volunteers. Invest. Ophthalmol. 14 (1975) 848-853
60. Gaasterland D., Kupfer C., Milton R., Ross K., McCain L., and MacLellan H. Studies of aqueous humour dynamics in man. VI. Effect of age upon parameters of intraocular pressure in normal human eyes. Exp. Eye Res. 26 (1978) 651-656
61. Gabelt B.T., and Kaufman P.L. Changes in aqueous humor dynamics with age and glaucoma. Prog. Retin. Eye Res. 24 (2005) 612-637
62. Gabelt B.T., Gottanka J., Lütjen-Drecoll E., and Kaufman P.L. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2118-2125
63. Gabelt B.T., Okka M., Dean T.R., and Kaufman P.L. Aqueous humor dynamics in monkeys after topical R-DOI. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4691-4696
64. Galin M.A., Baras I., and Glenn J. L-epinephrine and intraocular pressure. Invest. Ophthalmol. 5 (1966) 120-124
65. Garner L.L., Johnstone W.W., Ballintine E.J., and Carroll M.E. Effect of 2% levo-rotary epinephrine on the intraocular pressure of the glaucomatous eye. AMA Arch. Ophthalmol. 62 (1959) 230-238
66. Gaul G.R., Will N.J., and Brubaker R.F. Comparison of a noncardioselective beta-adrenoceptor blocker and a cardioselective blocker in reducing aqueous flow in humans. Arch. Ophthalmol. 107 (1989) 1308-1311
67. Gharagozloo N.Z., and Brubaker R.F. Effect of apraclonidine in long-term timolol users. Ophthalmology 98 (1991) 1543-1546
68. Gharagozloo N.Z., Relf S.J., and Brubaker R.F. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 95 (1988) 1217-1220
69. Gharagozloo N.Z., Baker R.H., and Brubaker R.F. Aqueous dynamics in exfoliation syndrome. Am. J. Ophthalmol. 114 (1992) 473-478
70. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K.I., Wilson M.R., Kass M.A., and for the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 714-720
71. Grant W.M. Clinical measurements of aqueous outflow. AMA Arch. Ophthalmol. 46 (1951) 113-131
72. Grant W.M., and Trotter R.R. Diamox (acetazolamide) in treatment of glaucoma. A. M. A. Arch. Ophthalmol. 51 (1954) 735-739
73. Haidle A.M., and Myers A.G. An enantioselective, modular, and general route to the cytochalasins: Synthesis of L-696,474 and cytochalasin B. Proc. Natl. Acad. Sci. USA 101 (2004) 12048-12053
74. Hammer T., Schlötzer-Schrehardt U., and Naumann G.O.H. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch. Ophthalmol. 119 (2001) 1023-1031
75. Haria M., and Spencer C.M. Unoprostone (isopropyl unoprostone). Drugs Aging 9 (1996) 213-218
76. Hart C.T., and Weatherill J.R. Gonioscopy and tonography in glaucomatocyclitic crises. Br. J. Ophthalmol. 52 (1968) 682-687
77. Hayashi M., Yablonski M.E., Boxrud C., Fong N., Berger C., and Jovanovic L.J. Decreased formation of aqueous humour in insulin-dependent diabetic patients. Br. J. Ophthalmol. 73 (1989) 621-623
78. Hayashi M., Yablonski M.E., and Novack G.D. Trabecular outflow facility determined by fluorophotometry in human subjects. Exp. Eye Res. 48 (1989) 621-625
79. Hayreh S.S., Zimmerman M.B., Podhajsky P., and Alward W.L.M. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am. J. Ophthalmol. 117 (1994) 603-624
80. Higgins R.G., and Brubaker R.F. Acute effect of epinephrine on aqueous humor formation in the timolol-treated normal eye as measured by fluorophotometry. Invest. Ophthalmol. Vis. Sci. 19 (1980) 420-423
81. Higgitt A.C. Secondary glaucoma. Trans. Opthal. Soc. UK 76 (1956) 73-82
82. Honjo M., Tanihara H., Inatani M., Kido N., Sawamura T., Yue B.Y.J., Narumiya S., and Honda Y. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42 (2001) 137-144
83. Inoue T., Yokoyoma T., and Koike H. The effect of angiotensin II on uveoscleral outflow in rabbits. Curr. Eye Res. 23 (2001) 139-143
84. 1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits. Curr. Eye Res. 23 (2001) 133-138
85. Johnson D., Liesegang T.J., and Brubaker R.F. Aqueous humor dynamics in Fuchs' uveitis syndrome. Am. J. Ophthalmol. 95 (1983) 783-787
86. Johnson D.H. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Invest. Ophthalmol. Vis. Sci. 38 (1997) 2790-2799
87. Johnson D.H., and Brubaker R.F. Dynamics of aqueous humor in the syndrome of exfoliation with glaucoma. Am. J. Ophthalmol. 93 (1982) 629-634
88. Johnson T.V., Fan S., Camras C.B., and Toris C.B. Aqueous humor dynamics in exfoliation syndrome. Arch. Ophthalmol. 126 (2008) 1-7
89. Johnstone M., Tanner D., Chau B., and Kopecky K. Concentration-dependent morphologic effects of cytochalasin B in the aqueous outflow system. Invest. Ophthalmol. Vis. Sci. 19 (1980) 835-841
90. Joseph J., and Grierson I. Anterior seqment changes in glaucoma. In: Garner A., and Klintworth G.K. (Eds). Pathobiology of Ocular Disease; a Dynamic Approach (1994), Marcel Dekker, New York 433-468
91. Kacere R.D., Dolan J.W., and Brubaker R.F. Intravenous epinephrine stimulates aqueous formation in the human eye. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2861-2865
92. Kalina P.H., Shetlar D.J., Lewis R.A., Kullerstrand L.J., and Brubaker R.F. 6-Amino-2-benzothiazole-sulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye. Ophthalmology 95 (1988) 772-777
93. Kass M.A., Becker B., and Kolker A.E. Glaucomatocyclitic crisis and primary open-angle glaucoma. Am. J. Ophthalmol. 75 (1973) 668-673
94. Katz I.M., Hubbard W.A., Getson A.J., and Gould A.L. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest. Ophthalmol. 15 (1976) 489-492
95. Kaufman P.L., and Bárány E.H. Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 16 (1977) 47-53
96. Kaufman P.L., and Erickson K.A. Cytochalasin B and D dose-outflow facility response relationships in the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 23 (1982) 646-650
97. Kaufman P.L., and Gabelt B.T. Aging, accommodation and outflow facility. In: Lütjen-Drecoll E. (Ed). Basic Aspects of Glaucoma Research III (1993), Schattauer, Stuttgart 257-274
98. Kaufman P.L., and Gabelt B.T. Direct, indirect, and dual-action parasympathetic drugs. In: Zimmerman T.J., Kooner K.S., Sharir M., and Fechtner R.D. (Eds). Textbook of Ocular Pharmacology (1997), Lippincott-Raven, Philadelphia 221-238
99. Kent A.R., Vroman D.T., Thomas T.J., Herbert R.L., and Crosson C.E. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J. Glaucoma 8 (1999) 257-262
100. Khan A.R., and Brubaker R.F. Aqueous humor flow and flare in patients with myotonic dystrophy. Invest. Ophthalmol. Vis. Sci. 34 (1993) 3131-3139
101. Kiel J.W. The effect of arterial pressure on the ocular pressure-volume relationship in the rabbit. Exp. Eye Res. 60 (1995) 267-278
102. Koskela T., and Brubaker R.F. Apraclonidine and timolol. Combined effects in previously untreated normal subjects. Arch. Ophthalmol. 109 (1991) 804-806
103. Koskela T., and Brubaker R.F. The nocturnal suppression of aqueous humor flow in humans is not blocked by bright light. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2504-2506
104. Kronfeld P.C. Society Proceedings, Glaucoma Research Conference. In: Lyle D.J. (Ed). Am.J.Ophthalmol. 55 (1963) 821-832 Del Monte, CA
105. Kubo C., and Suzuki R. Involvement of prejunctional alpha 2-adrenoceptor in bovine ciliary muscle movement. J. Ocul. Pharmacol. 8 (1992) 225-231
106. Kupfer C., and Ross K. Studies of aqueous humor dynamics in man. I. Measurements in young normal subjects. Invest. Ophthalmol. 10 (1971) 518-522
107. Kupfer C., Gaasterland D., and Ross K. Studies of aqueous humor dynamics in man. II. Measurements in young normal subjects using acetazolamide and L-epinephrine. Invest. Ophthalmol. 10 (1971) 523-533
108. Lane J.T., Toris C.B., Nakhle S.N., Chacko D.M., Wang Y.-L., and Yablonski M.E. Acute effects of insulin on aqueous humor flow in patients with type 1 diabetes. Am. J. Ophthalmol. 132 (2001) 321-327
109. Larsson L.-I. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination. Arch. Ophthalmol. 119 (2001) 492-495
110. Larsson L.-I., Rettig E.S., Sheridan P.T., and Brubaker R.F. Aqueous humor dynamics in low-tension glaucoma. Am. J. Ophthalmol. 116 (1993) 590-593
111. Larsson L.-I., Pach J.M., and Brubaker R.F. Aqueous humor dynamics in patients with diabetes mellitus. Am. J. Ophthalmol. 120 (1995) 362-367
112. Larsson L.-I., Rettig E.S., and Brubaker R.F. Aqueous flow in open-angle glaucoma. Arch. Ophthalmol. 113 (1995) 283-286
113. Lee D.A., Brubaker R.F., and Nagataki S. Acute effect of thymoxamine on aqueous humor formation in the epinephrine-treated normal eye as measured by fluorophotometry. Invest. Ophthalmol. Vis. Sci. 24 (1983) 165-168
114. Lee P.-Y., Serle J.B., Podos S.M., and Severin C. Time course of the effect of UK 14304-18 (brimonidine tartrate) on rabbit uveoscleral outflow. Invest. Ophthalmol. Vis. Sci. 33 (1992) 1118 Abstract
115. Lim K.S., Nau C.B., O'Byrne M.M., Hodge D., Toris C.B., McLaren J.W., and Johnson D.H. Comparative study on the mechanism of action of bimatoprost, latanoprost and travoprost in healthy subjects. A double-masked, placebo-controlled, randomized, paired comparison, 4-session crossover study. Ophthalmology 115 (2008) 790-795
116. Lindén C., and Alm A. Effects on intraocular pressure and aqueous flow of various dose regimens of latanoprost in human eyes. Acta Ophthalmol. 75 (1997) 412-415
117. Lindén C., and Alm A. Physostigmine increases aqueous humor production in human eyes. Curr. Eye Res. 16 (1997) 1166-1170
118. Liu J.H.K., Kripke D.F., Hoffman R.E., Twa M.D., Loving R.T., Rex K.M., Gupta N., and Weinreb R.N. Nocturnal elevation of intraocular pressure in young adults. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2707-2712
119. Liu J.H.K., Kripke D.F., Hoffman R.E., Twa M.D., Loving R.T., Rex K.M., Lee B.L., Mansberger S.L., and Weinreb R.N. Elevation of human intraocular pressure at night under moderate illumination. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2439-2442
120. Liu J.H.K., Kripke D.F., Twa M.D., Hoffman R.E., Mansberger S.L., Rex K.M., Girkin C.A., and Weinreb R.N. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2912-2917
121. Liu J.H.K., Zhang X., Kripke D.F., and Weinreb R.N. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1586-1590
122. Luksch A., Polak K., Matulla B., Dallinger S., Kapiotis S., Rainer G., Wolzt M., and Schmetterer L. Glucose and insulin exert additive ocular and renal vasodilator effects on healthy humans. Diabetologia 44 (2001) 95-103
123. 2α. Exp. Eye Res. 47 (1988) 761-769
124. 1-like receptor sites in the ciliary body of the rabbit eye by light microscope autoradiography. Naunyn Schmiedebergs Arch. Pharmacol. 346 (1992) 644-648
125. Mansheim B.J. Aqueous outflow measurements by continuous tonometry in some unusual forms of glaucoma. AMA Arch. Ophthalmol. 50 (1953) 580-587
126. Maren T.H. Carbonic anhydrase: General perspectives and advances in glaucoma research. Drug Dev. Res. 10 (1987) 255-276
127. Maren T.H., Haywood J.R., Chapman S.K., and Zimmerman T.J. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest. Ophthalmol. Vis. Sci. 16 (1977) 730-742
128. Martin X.D., Brennan M.C., and Lichter P.R. Serotonin in human aqueous humor. Ophthalmology 95 (1988) 1221-1226
129. Martin P.B., Vila P.C.F., Martinez T.M.P., and Peréz D.A. A fluorophotometric study on the aqueous humor dynamics in primary open angle glaucoma. Int. Ophthalmol. 16 (1992) 311-314
130. Martin X.D., Malina H.Z., Brennan M.C., Hendrickson P.H., and Lichter P.R. The ciliary body-the third organ found to synthesize indoleamines in humans. Eur. J. Ophthalmol. 2 (1992) 67-72
131. Masuda K., Izawa Y., and Mishima S. Prostaglandins and glaucomato-cyclitic crisis. Jpn. J. Ophthalmol. 19 (1975) 368-375
132. Maus T.L., Larsson L.-I., McLaren J.W., and Brubaker R.F. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch. Ophthalmol. 115 (1997) 45-49
133. Maus T.L., Nau C., and Brubaker R.F. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Arch. Ophthalmol. 117 (1999) 586-591
134. McCannel C.A., Heinrich S.R., and Brubaker R.F. Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch. Clin. Exp. Ophthalmol. 230 (1992) 518-520
135. McLaren J.W., Herman D.C., Brubaker R.F., Nau C.B., Wayman L.L., Ciarniello M.G., Rosignoli M.T., and Dionisio P. Effect of ibopamine on aqueous humor production in normotensive humans. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4853-4858
136. McLaughlin M.A., Toris C.B., Brooks D.E., Scott D.A., Cage T., Fan S., Zhan G.-L., Ollivier F.J., Camras C.B., and Holt W.F. Effects of rho kinase inhibitors on intraocular pressure (IOP) and aqueous humor dynamics in rabbits and monkeys. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3534
137. Michel M.C., and Ernsberger P. Keeping an eye on the I site: Imidazoline-preferring receptors. Trends Pharmacol. Sci. 13 (1992) 369-370
138. Mishima H.K., Kiuchi Y., Takamatsu M., Rácz P., and Bito L.Z. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Surv. Ophthalmol. 41 (1997) S139-S144
139. Mori M., Araie M., Sakurai M., and Oshika T. Effects of pilocarpine and tropicamide on blood-aqueous barrier permeability in man. Invest. Ophthalmol. Vis. Sci. 33 (1992) 416-423
140. Nagataki S. Effects of adrenergic drugs on aqueous humor dynamics in man. J. Jpn. Ophthalmol. Soc. 81 (1977) 1795-1800
141. Nagataki S., and Brubaker R.F. Early effect of epinephrine on aqueous formation in the normal human eye. Ophthalmology 88 (1981) 278-282
142. Nagataki S., and Brubaker R.F. Effect of pilocarpine on aqueous humor formation in human beings. Arch. Ophthalmol. 100 (1982) 818-821
143. Nagataki S., and Mishima S. Aqueous humor dynamics in glaucomato-cyclitic crisis. Invest. Ophthalmol. 15 (1976) 365-370
144. Nelson W.L., Fraunfelder F.T., Sills J.M., Arrowsmith J.B., and Kuritsky J.N. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1987-1985. Am. J. Ophthalmol. 102 (1986) 606-611
145. 2 α-IE) on uveoscleral outflow. In: Bito L.Z., and Stjernschantz J. (Eds). The Ocular Effects of Prostaglandins and Other Eicosanoids Vol. 312 (1989), Alan R. Liss, Inc, New York, USA 429-436
146. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp. Eye Res. 67 (1998) 179-191
147. Okka M., Tian B., and Kaufman P.L. Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys. Trans. Am. Ophthalmol. Soc. 102 (2004) 251-257
148. Ortiz G.J., Cook D.J., Yablonski M.E., Masonson H., and Harmon G. Effect of cold air on aqueous humor dynamics in humans. Invest. Ophthalmol. Vis. Sci. 29 (1988) 138-140
149. Patelska B., Greenfield D.S., Liebmann J.M., Wand M., Kushnick H., and Ritch R. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am. J. Ophthalmol. 124 (1997) 279-286
150. Pederson J.E. Ocular hypotony. Trans. Ophthalmol. Soc. UK 105 (1986) 220-226
151. Peterson J.A., Tian B., Bershadsky A.D., Volberg T., Gangnon R.E., Spector I., Geiger B., and Kaufman P.L. Latrunculin-A increases outflow facility in the monkey. Invest. Ophthalmol. Vis. Sci. 40 (1999) 931-941
152. Peterson J.A., Tian B., McLaren J.W., Hubbard W.C., Geiger B., and Kaufman P.L. Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1749-1758
153. Phillips C.I., Howitt G., and Rowlands D.J. Propranolol as ocular hypotensive agent. Br. J. Ophthalmol. 51 (1967) 222-226
154. Piltz J.R., Stone R.A., Boike S., Everitt D.E., Shusterman N.H., Audet P., Zariffa N., and Jorkasky D.K. Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure. J. Ocul. Pharmacol. Ther. 14 (1998) 203-216
155. Plange N., Kaup M., Daneljan L., Predel H.G., Remky A., and Arend O. 24-h blood pressure monitoring in normal tension glaucoma: Night-time blood pressure variability. J. Hum. Hypertens 20 (2006) 137-142
156. Posner A., and Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch. Ophthalmol. 39 (1948) 517-535
157. 2-adrenoceptors. Proc. West. Pharmacol. Soc. 33 (1990) 257-260
158. 2 α effects on isolated rhesus monkey ciliary muscle. Invest. Ophthalmol. Vis. Sci. 36 (1995) 2461-2465
159. Prünte C., Nuttli I., Markstein R., and Kohler C. Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits. J. Neural Transm. 104 (1997) 111-123
160. Ramirez M., Davidson E.A., Luttenauer L., Elena P.-P., Cumin F., Mathis G.A., and De Gasparo M. The renin-angiotensin system in the rabbit eye. J. Ocul. Pharmacol. Ther. 12 (1996) 299-312
161. Rao P.V., Deng P.-F., Kumar J., and Epstein D.L. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1029-1037
162. Read A.T., Chan D.W.-H., and Ethier C.R. Actin structure in the outflow tract of normal and glaucomatous eyes. Exp. Eye Res. 84 (2007) 214-226
163. Reiss G.R., and Brubaker R.F. The mechanism of betaxolol, a new ocular hypotensive agent. Ophthalmology 90 (1983) 1369-1372
164. Reiss G.R., Lee D.A., Topper J.E., and Brubaker R.F. Aqueous humor flow during sleep. Invest. Ophthalmol. Vis. Sci. 25 (1984) 776-778
165. Reitsamer H.A., and Kiel J.W. A rabbit model to study orbital venous pressure, intraocular pressure, and ocular hemodynamics simultaneously. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3728-3734
166. Reitsamer H.A., and Kiel J.W. Effects of dopamine on ciliary blood flow, aqueous production, and intraocular pressure in rabbits. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2697-2703
167. Reitsamer H.A., Posey M., and Kiel J.W. Effects of a topical α2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits. Exp. Eye Res. 82 (2006) 405-415
168. Rosenberg L.F., Krupin T., Tang L.-Q., Hong P.H., and Ruderman J.M. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. Ophthalmology 105 (1998) 88-93
169. Rosenthal R., Choritz L., Schlott S., Bechrakis N.E., Jaroszewski J., Wiederholt M., and Thieme H. Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork. Exp. Eye Res. 80 (2005) 837-845
170. Sabanay I., Tian B., Gabelt B.T., Geiger B., and Kaufman P.L. Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys. Exp. Eye Res. 82 (2006) 236-246
171. 2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch. Ophthalmol. 117 (1999) 794-801
172. Sakurai M., Araie M., Oshika T., Mori M., Masuda K., Ueno R., and Takase M. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn. J. Ophthalmol. 35 (1991) 156-165
173. Savaskan E., Löffler K.U., Meier F., Müller-Spahn F., Flammer J., and Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 36 (2004) 312-320
174. Schadlu R., Maus T.L., Nau C.B., and Brubaker R.F. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans. Arch. Ophthalmol. 116 (1998) 1441-1444
175. Schenker H.I., Yablonski M.E., Podos S.M., and Linder L. Fluorophotometric study of epinephrine and timolol in human subjects. Arch. Ophthalmol. 99 (1981) 1212-1216
176. Schlecht L.P., and Brubaker R.F. The effects of withdrawal of timolol in chronically treated glaucoma patients. Ophthalmology 95 (1988) 1212-1216
177. Schlötzer-Schrehardt U., and Naumann G.O.H. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest. Ophthalmol. Vis. Sci. 36 (1995) 1750-1764
178. Schmetterer L., Müller M., Fasching P., Diepolder C., Gallenkamp A., Zanaschka G., Findl O., Strenn K., Mensik C., Tschernko E., Eichler H.-G., and Wolzt M. Renal and ocular hemodynamic effects of insulin. Diabetes 46 (1997) 1868-1874
179. Schneider T.L., and Brubaker R.F. Effect of chronic epinephrine on aqueous humor flow during the day and during sleep in normal healthy subjects. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2507-2510
180. 2A) receptors: Role in IOP reduction. Invest. Ophthalmol. Vis. Sci. 47 (2006) 4001-4010
181. Shin D.H., McCracken M.S., Bendel R.E., Pearlman R., Juzych M.S., Hughes B.A., Schulz L.L., Kim C., and Baek N.H. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose and no pilocarpine therapy. Ophthalmology 106 (1999) 386-390
182. Sihota R., Lakshmaiah N.C., Walia K.B., Sharma S., Pailoor J., and Agarwal H.C. The trabecular meshwork in acute and chronic angle closure glaucoma. Indian J. Ophthalmol. 49 (2001) 255-259
183. Skorobohach B.J., Ward D.A., and Hendrix D.V.H. Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am. J. Vet. Res. 64 (2003) 183-187
184. Spivey B.E., and Armaly M.F. Tonographic findings in glaucomatocyclitic crises. Am. J. Ophthalmol. 55 (1963) 47-51
185. Sponsel W.E., Paris G., Trigo Y., Pena M., Weber A., Sanford K., and McKinnon S. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy. Am. J. Ophthalmol. 133 (2002) 11-18
186. Stein A., Pinke R., Krupin T., Glabb E., Podos S.M., Serle J., and Maren T.H. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. Am. J. Ophthalmol. 95 (1983) 222-228
187. 2α-isopropyl ester to latanoprost: A review of the development of xalatan: The Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1134-1145
188. Stjernschantz J., Selén G., Ocklind A., and Resul B. Effects of latanoprost and related prostaglandin analogues. In: Alm A., and Weinreb R.N. (Eds). Uveoscleral Outflow. Biology and Clinical Aspects (1998), Mosby International Limited, London, UK 57-72
189. Sugar H.S. Heterochromia iridis with special consideration of its relation to cyclitic disease. Am. J. Ophthalmol. 60 (1965) 1-18
190. Svedbergh B., Lütjen-Drecoll E., Ober M., and Kaufman P.L. Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 17 (1978) 718-734
191. 2α. Fortschr. Ophthalmol. 87 (1990) 623-629
192. Tetsuka H., Tsuchisaka H., Kin K., Takahashi Y., and Takase M. A mechanism for reducing intraocular pressure in normal volunteers using UF-021, a prostaglandin-related compound. J. Jpn. Ophthalmol. Soc. 96 (1992) 496-500
193. Tian B., Geiger B., Epstein D.L., and Kaufman P.L. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. 41 (2000) 619-623
194. Tobin A.B., Unger W., and Osborne N.N. Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J. Neurosci. 8 (1988) 3713-3721
195. Topper J.E., and Brubaker R.F. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1315-1319
196. Toris C.B., and Pederson J.E. Effect of intraocular pressure on uveoscleral outflow following cyclodialysis in the monkey eye. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1745-1749
197. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 100 (1993) 1297-1304
198. Toris C.B., Gleason M.L., Camras C.B., and Yablonski M.E. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch. Ophthalmol. 113 (1995) 1514-1517
199. Toris C.B., Tafoya M.E., Camras C.B., and Yablonski M.E. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology 102 (1995) 456-461
200. 2 increases uveoscleral outflow and trabecular outflow facility in the cat. Exp. Eye Res. 61 (1995) 649-657
201. Toris C.B., Camras C.B., and Yablonski M.E. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am. J. Ophthalmol. 128 (1999) 8-14
202. Toris C.B., Yablonski M.E., Wang Y.-L., and Camras C.B. Aqueous humor dynamics in the aging human eye. Am. J. Ophthalmol. 127 (1999) 407-412
203. Toris C.B., Zhan G.-L., Wang Y.-L., Zhao J., McLaughlin M.A., Camras C.B., and Yablonski M.E. Aqueous humor dynamics in monkeys with laser-induced glaucoma. J. Ocul. Pharmacol. Ther. 16 (2000) 19-27
204. Toris C.B., Zhan G.-L., Zhao J., Camras C.B., and Yablonski M.E. Potential mechanism for the additivity of pilocarpine and latanoprost. Am. J. Ophthalmol. 131 (2001) 722-728
205. Toris C.B., Koepsell S.A., Yablonski M.E., and Camras C.B. Aqueous humor dynamics in ocular hypertensive patients. J. Glaucoma 11 (2002) 253-258
206. Toris C.B., Zhan G.-L., Yablonski M.E., and Camras C.B. Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide. J. Glaucoma 13 (2004) 210-215
207. Toris C.B., Zhan G., and Camras C.B. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients. Arch. Ophthalmol. 122 (2004) 1782-1787
208. Toris C.B., Zhan G., Fan S., Dickerson J.E., Landry T.A., Bergamini M.V.W., and Camras C.B. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. J. Glaucoma 16 (2007) 189-195
209. Townsend D.J., and Brubaker R.F. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest. Ophthalmol. Vis. Sci. 19 (1980) 256-266
210. Tsukamoto H., and Larsson L.-I. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination. Arch. Ophthalmol. 122 (2004) 190-193
211. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
212. Van Alphen G.W.H.M., Wilhelm P.B., and Elsenfeld P.W. The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man. Doc. Ophthalmol. 42 (1977) 397-415
213. Veglio F., De Sanctis U., Schiavone D., Cavallone S., Mulatero P., Grignolo F.M., and Chiandussi L. Evaluation of serotonin levels in human aqueous humor. Ophthalmologica 212 (1998) 160-163
214. 2α analogue PhXA41 in eyes treated with pilocarpine and timolol. Invest. Ophthalmol. Vis. Sci. 33 (1992) 1248 Abstract
215. Virno M., Gazzaniga A., Taverniti L., Pecori G.J., and De Gregorio F. Dopamine, dopaminergic drugs and ocular hypertension. Int. Ophthalmol. 16 (1992) 349-353
216. Virno M., Taverniti L., De Gregorio F., Sedran L., and Longo F. Increase in aqueous humor production following D1 receptors activation by means of ibopamine. Int. Ophthalmol. 20 (1997) 141-146
217. Vogh B.P., Godman D.R., and Maren T.H. Measurement of aqueous humor flow following scleral injection of sulfacetamide as marker: effect of methazolamide, timolol, and pilocarpine. J. Ocul. Pharmacol. 5 (1989) 293-302
218. Waki M., Yoshida Y., Oka T., and Azuma M. Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr. Eye Res. 22 (2001) 470-474
219. Walker S.D., Brubaker R.F., and Nagataki S. Hypotony and aqueous humor dynamics in myotonic dystrophy. Invest. Ophthalmol. Vis. Sci. 22 (1982) 744-751
220. Wang Y.-L., Hayashi M., Yablonski M.E., and Toris C.B. Effects of multiple dosing of epinephrine on aqueous humor dynamics in human eyes. J. Ocul. Pharmacol. Ther. 18 (2002) 53-63
221. 1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp. Eye Res. 80 (2005) 629-632
222. Wayman L., Larsson L.-I., Maus T., Alm A., and Brubaker R.F. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch. Ophthalmol. 115 (1997) 1368-1371
223. Wayman L.L., Larsson L.-I., Maus T.L., and Brubaker R.F. Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol. Arch. Ophthalmol. 116 (1998) 1438-1440
224. e partie: Mode d'action de l'adrénaline dans le glaucome chronique. Ophthalmologica 128 (1954) 213-217
225. Weekers R., Prijot E., and Gustin J. Recent advances and future prospects in the medical treatment of ocular hypertension. Br. J. Ophthalmol. 38 (1954) 742-746
226. Weinreb R.N., and Liu J.H. Nocturnal rhythms of intraocular pressure. Arch. Ophthalmol. 124 (2006) 269-270
227. Weinreb R.N., Kashiwagi K., Kashiwagi F., Tsukahara S., and Lindsey J.D. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38 (1997) 2772-2780
228. Weinreb R.N., Toris C.B., Gabelt B.T., Lindsey J.D., and Kaufman P.L. Effects of prostaglandins on the aqueous humor outflow pathways. Surv. Ophthalmol. 47 (2002) S53-S64
229. Wentworth W.O., and Brubaker R.F. Aqueous humor dynamics in a series of patients with third neuron Horner's syndrome. Am. J. Ophthalmol. 92 (1981) 407-415
230. Wiederholt M., Bielka S., Schweig F., Lütjen-Drecoll E., and Lepple-Wienhues A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp. Eye Res. 61 (1995) 223-234
231. Wiederholt M., Thieme H., and Stumpff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog. Retin. Eye Res. 19 (2000) 271-295
232. Woodward D.F., Krauss A.H.P., Chen J., Liang Y., Li C., Protzman C.E., Bogardus A., Chen R., Kedzie K.M., Krauss H.A., Gil D.W., Kharlamb A., et al. Pharmacological characterization of a novel antiglaucoma agent, bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther. 305 (2003) 772-785
233. Yablonski M.E., Cook D.J., and Gray J. A fluorophotometric study of the effect of argon laser trabeculoplasty on aqueous humor dynamics. Am. J. Ophthalmol. 99 (1985) 579-582
234. Yablonski M.E., Gallin P., and Shapiro D. Effect of oxygen on aqueous humor dynamics in rabbits. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1781-1784
235. Yablonski M.E., Zimmerman T.J., Waltman S.R., and Becker B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp. Eye Res. 27 (1978) 135-142
236. Yablonski M.E., Novack G.D., Burke P.J., Cook D.J., and Harmon G. The effect of levobunolol on aqueous humor dynamics. Exp. Eye Res. 44 (1987) 49-54
237. Zeimer R.C. Episcleral venous pressure. In: Ritch R., Shields M.B., and Krupin T. (Eds). The Glaucomas (1989), The C. V. Mosby Company, St. Louis 249-255
238. Zeimer R.C., Gieser D.K., Wilensky J.T., Noth J.M., Mori M.M., and Odunukwe E.E. A practical venomanometer. Measurement of episcleral venous pressure and assessment of the normal range. Arch. Ophthalmol. 101 (1983) 1447-1449
239. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch. Ophthalmol. 111 (1993) 1351-1358
240. Zimmerman T.J., and Kaufman H.E. Timolol, dose response and duration of action. Arch. Ophthalmol. 95 (1977) 605-607